We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$2.21B
AUM Growth
+$72.6M
Cap. Flow
-$21M
Cap. Flow %
-0.95%
Top 10 Hldgs %
34.85%
Holding
309
New
67
Increased
119
Reduced
68
Closed
44

Top Buys

Rank Stock Value
1
FFIV icon
F5
FFIV
+$50.6M
2
GLW icon
Corning
GLW
+$32.8M
3
BLK icon
Blackrock
BLK
+$31.6M
4
FLR icon
Fluor
FLR
+$26.6M
5
COHR icon
Coherent
COHR
+$26.5M

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$94.6M
2
COR icon
Cencora
COR
+$53.7M
3
AZN icon
AstraZeneca
AZN
+$33.6M
4
ATI icon
ATI
ATI
+$33.4M
5
TXT icon
Textron
TXT
+$28.6M

Sector Composition

Rank Sector Weight
1 Technology 26.54%
2 Financials 19.31%
3 Industrials 15.96%
4 Consumer Discretionary 13.82%
5 Healthcare 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
26
Teva Pharmaceuticals
TEVA
$40.8B
$27.5M 1.25%
1,249,126
-14,346
-1% -$261K
COHR icon
27
Coherent
COHR
$51.4B
$27M 1.22%
284,642
+264,425
+1,308% +$26.5M
SHAK icon
28
Shake Shack
SHAK
$2.53B
$26.8M 1.21%
+206,136
New +$25.3M
BKNG icon
29
Booking.com
BKNG
$149B
$26.6M 1.21%
133,850
+4,400
+3% +$846K
CRBG icon
30
Corebridge Financial
CRBG
$14.1B
$25.2M 1.14%
842,508
+68,404
+9% +$2.11M
FLR icon
31
Fluor
FLR
$7.01B
$24.8M 1.13%
+503,833
New +$26.6M
BSX icon
32
Boston Scientific
BSX
$69.5B
$23.1M 1.05%
259,018
+1,813
+0.7% +$160K
TOL icon
33
Toll Brothers
TOL
$13.6B
$22M 1%
174,422
-9,139
-5% -$1.36M
ALLE icon
34
Allegion
ALLE
$13.4B
$21.7M 0.98%
+165,780
New +$23.5M
ACGL icon
35
Arch Capital
ACGL
$34.3B
$20.6M 0.93%
222,635
-10,509
-5% -$1.06M
DUOL icon
36
Duolingo
DUOL
$6.28B
$20.5M 0.93%
+63,203
New +$20.1M
MSI icon
37
Motorola Solutions
MSI
$72.3B
$19.4M 0.88%
41,975
+538
+1% +$255K
VTR icon
38
Ventas
VTR
$48B
$19.3M 0.87%
327,415
+555
+0.2% +$34.9K
SSNC icon
39
SS&C Technologies
SSNC
$18.6B
$18.9M 0.86%
248,953
-767
-0.3% -$57.4K
KKR icon
40
KKR & Co
KKR
$91.1B
$17.2M 0.78%
116,540
-7
-0% -$1.03K
ONON icon
41
On Holding
ONON
$12.1B
$14.8M 0.67%
270,749
+33,384
+14% +$1.77M
FRPT icon
42
Freshpet
FRPT
$2.93B
$14.6M 0.66%
98,865
+114
+0.1% +$16.6K
ARGX icon
43
argenx
ARGX
$53.4B
$14.4M 0.65%
23,483
-83
-0.4% -$48.6K
GS icon
44
Goldman Sachs
GS
$300B
$14M 0.63%
24,419
-12
-0% -$6.69K
OHI icon
45
Omega Healthcare
OHI
$15.1B
$13.9M 0.63%
368,127
+14,883
+4% +$595K
LNG icon
46
Cheniere Energy
LNG
$55.2B
$13.1M 0.59%
+60,997
New +$12.4M
NVDA icon
47
NVIDIA
NVDA
$4.86T
$12.9M 0.58%
95,959
-1,007
-1% -$139K
ALL icon
48
Allstate
ALL
$68B
$12.9M 0.58%
66,678
+802
+1% +$156K
BCS icon
49
Barclays
BCS
$92.7B
$11.9M 0.54%
897,572
+9,756
+1% +$126K
SF
50
Stifel
SF
$12.6B
$11.9M 0.54%
167,589
-176
-0.1% -$12.6K

Similar funds

Cookson Peirce & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Cookson Peirce & Co held 309 positions worth $2.21B, up 3.4% from $2.13B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Cookson Peirce & Co's Q4 2024 filing shows 67 new, 119 increased, 68 reduced and 44 closed positions. Its largest new stake was F5: 211,603 shares worth $53.2M. The largest sale was KLA, an estimated $94.6M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.

  • Cookson Peirce & Co's largest Q4 2024 buy was F5: 211,603 shares worth $53.2M.
  • Cookson Peirce & Co added most to Corning in Q4 2024, an estimated $32.8M increase.
  • Cookson Peirce & Co's biggest Q4 2024 reduction was KLA, cutting an estimated $94.6M.
  • Cookson Peirce & Co fully exited Cencora in Q4 2024, selling an estimated $53.7M.
  • Cookson Peirce & Co's ten largest holdings make up 35% of its $2.21B portfolio in Q4 2024.
  • Cookson Peirce & Co opened 67 new positions and closed 44 in Q4 2024.
  • Cookson Peirce & Co's portfolio value rose 3.4% quarter-over-quarter to $2.21B.

Based on Cookson Peirce & Co's 13F filing for Q4 2024, filed 6 Feb 2025.